New research has revealed elevated risks of death during the COVID-19 pandemic for both COVID-19–positive and other patients on hemodialysis compared with hemodialysis patients treated in 2019. The findings will be presented at ASN Kidney Week 2022 November 3–November 6.
Both genetic and environmental factors contribute to chronic kidney disease (CKD). New research assessed the interaction of air pollution and genetic factors on the development of CKD.
Change in urinary albumin:creatinine ratio (UACR) and glomerular filtration rate (GFR) slope are markers that are individually used as surrogates of chronic kidney disease progression in clinical trials.
Individuals with chronic kidney disease (CKD) are vulnerable to developing severe forms of COVID-19, and acute kidney injury is a common complication of COVID-19.
For some individuals with advanced kidney disease, dialysis may not be the optimal treatment strategy for their condition, and these patients may be better served with conservative non-dialytic management that focuses on quality of life and symptom control.